Stockscreener 앱 받기
87.63
1.52%
-1.35
시간 외 거래:
87.47
-0.16
-0.18%
전일 마감가:
$88.98
열려 있는:
$87.85
하루 거래량:
6.32M
Relative Volume:
0.93
시가총액:
$112.37B
수익:
$33.20B
순이익/손실:
$4.26B
주가수익비율:
26.64
EPS:
3.29
순현금흐름:
$5.47B
1주 성능:
-2.99%
1개월 성능:
-3.43%
6개월 성능:
-1.89%
1년 성능:
+0.55%
1일 변동 폭
$87.23
$88.38
1주일 범위
$87.23
$90.84
52주 변동 폭
$75.96
$96.25
메드트로닉 Stock (MDT) Company Profile
명칭
Medtronic Plc
전화
01135314381700
주소
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
MDT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MDT
Medtronic Plc
|
87.63 | 112.37B | 33.20B | 4.26B | 5.47B | 3.29 |
|
ABT
Abbott Laboratories
|
130.82 | 226.88B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
99.36 | 146.96B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
364.50 | 142.81B | 22.60B | 2.99B | 3.49B | 7.76 |
|
EW
Edwards Lifesciences Corp
|
70.91 | 41.85B | 5.72B | 4.17B | 259.90M | 6.97 |
메드트로닉 Stock (MDT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-04 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-10-10 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-08-21 | 재확인 | Oppenheimer | Perform |
| 2024-08-15 | 업그레이드 | UBS | Sell → Neutral |
| 2024-08-14 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-05-30 | 개시 | Goldman | Sell |
| 2023-07-19 | 개시 | Robert W. Baird | Neutral |
| 2023-06-30 | 개시 | CL King | Buy |
| 2023-05-30 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-24 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-03-29 | 다운그레이드 | UBS | Buy → Sell |
| 2023-01-09 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-11-23 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-11-23 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2022-11-16 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2022-10-18 | 개시 | Barclays | Equal Weight |
| 2022-10-13 | 개시 | Mizuho | Buy |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-08-24 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2022-07-06 | 개시 | Wolfe Research | Underperform |
| 2022-06-01 | 다운그레이드 | Atlantic Equities | Overweight → Neutral |
| 2022-05-27 | 다운그레이드 | Needham | Buy → Hold |
| 2022-04-13 | 다운그레이드 | Truist | Buy → Hold |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-01-10 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2022-01-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-12-17 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-12-16 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2021-12-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-06-10 | 재개 | Cowen | Outperform |
| 2021-05-25 | 개시 | Barclays | Equal Weight |
| 2021-04-15 | 개시 | Atlantic Equities | Overweight |
| 2020-12-15 | 업그레이드 | Goldman | Sell → Neutral |
| 2020-12-15 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-10-08 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2020-10-08 | 업그레이드 | Stifel | Hold → Buy |
| 2020-09-11 | 개시 | Wolfe Research | Peer Perform |
| 2020-05-14 | 다운그레이드 | DZ Bank | Buy → Hold |
| 2020-03-30 | 다운그레이드 | Needham | Strong Buy → Buy |
| 2020-03-25 | 업그레이드 | DZ Bank | Hold → Buy |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Sell |
| 2020-01-08 | 개시 | SunTrust | Buy |
| 2020-01-02 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2019-06-05 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2019-02-04 | 재확인 | Needham | Strong Buy |
| 2019-01-03 | 개시 | Deutsche Bank | Buy |
| 2019-01-02 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2018-12-19 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-11-28 | 개시 | UBS | Buy |
| 2018-10-16 | 개시 | Barclays | Overweight |
| 2018-08-27 | 재확인 | Argus | Buy |
모두보기
메드트로닉 주식(MDT)의 최신 뉴스
Prediction: Buying Medtronic Today Will Set You Up for Life - The Motley Fool
Fed. Circ. Revives Recor's PTAB Challenge To Medtronic IP - Law360
Medtronic (MDT) Increases Despite Market Slip: Here's What You Need to Know - Yahoo Finance
Medtronic shares trade in green after seven straight days of losses - Seeking Alpha
Otsuka Gets Another Shot Challenging Medtronic Patent's Validity - Bloomberg Law
Medtronic Stock: A Great Business, But With Low Growth (NYSE:MDT) - Seeking Alpha
2 Recession-Proof Dividend Stocks to Buy and Hold - The Motley Fool
Is Medtronic plc (MDT) the Best Consistent Dividend Stock to Buy? - Insider Monkey
Ex-Dividend Reminder: Dick's Sporting Goods, Medtronic and DENTSPLY SIRONA - Nasdaq
Medtronic rolls out Affera PFA system in Sweden with more Nordic countries to follow - Mass Device
The Zacks Analyst Blog Boston Scientific, Abbott and Medtronic - Yahoo Finance
Recent U.S. Food and Drug Administration (FDA) approvals - Today's Medical Developments
Investors Heavily Search Medtronic PLC (MDT): Here is What You Need to Know - Yahoo Finance
Looking At Medtronic's Recent Unusual Options Activity - Benzinga
Catheters Market Is Booming Worldwide 2025-2032 | Medtronic, ConvaTec, Inc., Smith Medical, Hollister Incorporated - openPR
Medtronic reports first real-world data on smart insulin pen system - Mass Device
Medtronic’s Evolut trial outcome could shift US TAVR market - Yahoo Finance
Medtronic (MDT) Up 5.6% Since Last Earnings Report: Can It Continue? - Yahoo Finance
An Insider At Medtronic Lowered Their Holding Recently - Simply Wall St
Safety Needles Market Detailed In New Research Report 2025 | - openPR
Medtronic: Strength In Cardiac Ablation Solutions, Upgrade To Buy - Seeking Alpha
Medtronic, Abbott Block Boston Scientific Heart Valve IP - Law360
“A Lifesaving Opportunity” – Jim Cramer on Medtronic plc (MDT)’s AI-Powered Future - Insider Monkey
Latest device recalls include Medtronic embolization devices - BioWorld Online
Medtronic recalls embolization devices tied to 17 injuries, 4 deaths - MedTech Dive
Tubeless Insulin Pump Market Is Booming Worldwide | Medtronic - openPR
Medtronic recalls embolization device after reported deaths - Mass Device
Medtronic slips after FDA notice on product recall (update) - Seeking Alpha
FDA classifies recall of Medtronic embolization devices as 'most serious' - Reuters.com
FDA Says Medtronic Removes Unused 027 Compatible Pipeline Vantage Embolization Device With Shield Technology - Marketscreener.com
FDA classifies recall of Medtronic embolization devices as 'most serious' -March 18, 2025 at 02:13 pm EDT - Marketscreener.com
Why Medtronic (MDT) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Medtronic plc (MDT): Among the Best European Stocks to Buy According to Billionaires - Insider Monkey
Medtronic (MDT) Announces Transition of Principal Accounting Off - GuruFocus.com
Medtronic Announces Leadership Transition in Finance Department - TipRanks
10 Best European Stocks To Buy According to Billionaires - Insider Monkey
The Zacks Analyst Blog Highlights NVIDIA, Resmed, GE HealthCare And Medtronic - Barchart
The Zacks Analyst Blog Highlights NVIDIA, Resmed, GE HealthCare and Medtronic - Nasdaq
Medtronic’s SWOT analysis: stock poised for growth amid challenges - Investing.com
Electrophysiology Market to Reach $22.65 Bn, Globally, by 2030 at 14.4% CAGR | BOSTON SCIENTIFIC CORPORATION, - EIN News
Medtronic Seeks to Bolster Moat With Novel Cardiovascular Therapies - Morningstar
Medtronic Named One of the 2025 World’s Most Ethical Companies for the Third Time by Ethisphere - StreetInsider.com
SCAAR data Prevails for Medtronic paclitaxel-coated balloon - BioWorld Online
nVent Electric taps Medtronic's Gary Corona as CFO - MSN
nVent Electric taps Medtronic's Gary Corona as CFO (NVT:NYSE) - Seeking Alpha
ECG Cable and ECG Lead Wires Market Set to Witness Significant Growth by 2025-2032: 3M Company, Medtronic plc, - EIN News
Data supports Medtronic Prevail paclitaxel-coated balloon - Mass Device
메드트로닉 (MDT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.83%
자본화:
|
볼륨(24시간):